IREDA Q2 Results 2026 Today: Should You Buy Ahead of Earnings?

IREDA is a government-owned lender that finances renewable energy projects. It closed its insider trading window from 1 October 2026 ahead of the results, which is standard before a board meeting on quarterly numbers.

This guide covers the share price setup, the FY26 base, what to check in the IREDA Q2 results, the Gensol issue, the risks of buying ahead of earnings and what to watch after the numbers. It is educational and not a recommendation to buy or sell IREDA.

Click Here – Get Free Investment Predictions

IREDA Share Price Setup Ahead of the Results

Item	Detail	Source or basis
Price at 9:33 AM IST, 19 Oct	Rs 109.79, up 0.91% from Rs 108.80	Live quote
Day range so far	Rs 108.51 to Rs 109.99	Live quote
52-week high and low	Rs 156.75 and Rs 103.41	Live quote
Below the 52-week high	About 30%	My calculation
Above the 52-week low	About 6%	My calculation
Price on 5 Oct	About Rs 109.10, down 1.7% that day	Report dated 5 Oct

The stock has traded in a narrow band near Rs 109 for two weeks, so the IREDA Q2 results can move it out of that range. A narrow range before earnings means the market is waiting, and the reaction is often larger than the daily average.

Screen PSU stocks on the Univest Screener

FY26 Base: What IREDA Q2 Results Will Be Compared With

Metric	FY26	Note
Profit after tax	Rs 1,873 crore	Up 10%
Gross loan portfolio	Rs 93,069 crore	Year-end
Record disbursements	Rs 34,946 crore	Full year
Q2 FY26 profit and revenue (base for IREDA Q2 results)	Not found in the sources I read	Needed to judge YoY growth
IREDA Q2 results analyst estimates	Not found	No beat or miss can be confirmed

Without the Q2 FY26 base for the IREDA Q2 results, I cannot say what YoY growth the market expects. Check the company's filing for the IREDA Q2 results for the comparison, and compare Q2 with Q1 FY27 for the sequential trend.

What to Check in the IREDA Q2 Results

Line item	Why it matters	Warning sign
Loan book growth and disbursements	Shows demand for renewable project loans	Disbursements falling against the FY26 pace
Net interest margin and spread	IREDA earns the gap between lending and borrowing rates	Margin shrinking as funding costs rise
Gross and net NPA	Asset quality drives the valuation of a lender	A rise from the Gensol exposure
Provisions	Show how much stress is being recognised	A sharp jump in provisioning
Sanctions and pipeline	Indicate future disbursements	Slower sanctions
Management commentary	Guidance on growth and credit cost	Vague or lowered targets

The IREDA Q2 results also matter for the renewable sector, since the loan book reflects how many solar, wind and hydro projects are being financed. Higher global yields and a weak rupee can raise costs for borrowers.

Download the Univest iOS App or Univest Android App to track IREDA and set price alerts.

The Gensol Issue and Management News Before the IREDA Q2 Results

At its 39th AGM on 29 September 2026, IREDA declared fraud against Gensol Engineering. A fraud classification usually leads to full provisioning, so the Q2 numbers or commentary may show how much IREDA has set aside. I did not find the amount of the exposure in the sources I read, so check the filing.

The Ministry of New and Renewable Energy also granted a three-month extension to CMD Dr. Bijay Kumar Mohanty. Leadership continuity is a mild positive, but it does not replace clarity on credit quality.

Risk: If the Gensol provisioning is larger than expected, profit can fall even if the loan book grows.

Should You Buy Ahead of IREDA Q2 Results?

Approach	Upside	Downside
Buy before the IREDA Q2 results	Capture a rally if numbers beat	Gap down if provisions or margin disappoint
Wait for the numbers and commentary	Trade on facts, not guesses	May miss the first move
Stay out	Avoid event risk	May miss a re-rating

None of these is a recommendation. The point is that earnings are an event risk, and a lender with a fraud exposure carries more of it. If you hold the stock, decide in advance how much loss you can accept on a gap down.

What to Watch Next

1. The IREDA Q2 results filing: profit, net interest income, NPAs and provisions
2. Management commentary on Gensol and credit cost
3. Loan sanctions and disbursement guidance for the second half
4. The stock's reaction relative to its Rs 103.41 low and Rs 156.75 high
5. Renewable sector policy and funding news from MNRE

Conclusion

The IREDA Q2 results come with an open question on asset quality after the Gensol fraud declaration, and no consensus numbers to measure against. Read the filing before acting, and treat any pre-result position as a risk you can afford.

Frequently Asked Questions

When are the IREDA Q2 results?

Ans. They are due on Monday 19 October 2026 for the September quarter. I could not confirm the announcement time.

What was IREDA's FY26 profit and loan book?

Ans. Profit after tax rose 10% to Rs 1,873 crore, the gross loan portfolio was Rs 93,069 crore and record disbursements were Rs 34,946 crore.

What is the IREDA share price today?

Ans. It traded near Rs 109.79 at 9:33 AM IST on 19 October, up about 0.9%, with a 52-week range of Rs 103.41 to Rs 156.75.

What is the Gensol issue for IREDA?

Ans. IREDA declared fraud against Gensol Engineering at its AGM on 29 September 2026. The exposure amount was not in the sources I read.

What should I check in the IREDA Q2 results?

Ans. Loan book growth, disbursements, net interest margin, gross and net NPA, provisions, sanctions and management commentary.

Are there analyst estimates for IREDA Q2 results?

Ans. I did not find any in the sources I read, so a beat or a miss cannot be confirmed.

Is it safe to buy IREDA ahead of earnings?

Ans. No outcome is guaranteed. The stock can gap either way, and the Gensol exposure adds event risk.

Is this article investment advice?

Ans. No. It is educational and not a recommendation to buy or sell.